SAABY vs RMD
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SAABY · SAAB AB UNSPN ADS EACH REP 0.5 ORD SHS$30.50 ▼ 1.90%
RMD · ResMed$235.30 ▼ 1.68%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SAABY +10.5%
- RMD -4.9%
Head to head
| Metric | SAABY | RMD |
|---|---|---|
| Price | $30.50 | $235.30 |
| Change today | ▼ 1.90% | ▼ 1.68% |
| Market cap | $33.07B | $33.10B |
| Return, 3 months | -11.1% | +7.2% |
| Return, year to date | +5.5% | -1.5% |
| Return, 1 year | +12.5% | -5.4% |
| P/E (TTM) | 41.2 | 21.4 |
| P/B | 0.4 | 5.6 |
| P/E percentile vs own 5y | – | 7th |
| Dividend yield | 0.41% | 1.05% |
| Revenue growth (YoY, latest qtr) | – | +8.6% |
| Net profit growth (YoY) | – | +1.0% |
| Gross margin | – | 61.1% |
| Operating margin | – | 33.8% |
| Net margin | – | 26.9% |
| Return on equity | – | 24.3% |
| Analyst target vs. price | – | +14.2% |
| Analyst buy share | – | 44% |
| RSI (14) | 39 | 48 |
| 30-day volatility | 32.1% | 39.2% |
| Max drawdown, 1 year | -38.4% | -33.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- RMD is the largest of the group by market value.
- SAABY has returned the most over the past year.
- RMD carries the lowest trailing P/E.
- RMD pays the highest dividend yield.
- SAABY has been the calmest stock over the last 30 days.